Pending actions
144
Historical total
217
Resolved / remanded
73
Active. A substantial share of actions remain pending. Of 217 lawsuits ever part of this litigation, 144 remain active.
About this litigation
Generic Pharmaceuticals Pricing Antitrust Litigation is a federal multidistrict litigation classified by the Judicial Panel on Multidistrict Litigation as a Antitrust docket. It was centralized on August 5, 2016 before Cynthia M. Rufe, Sr. District Judge, in the E.D. Pennsylvania.
As of the August 3, 2026 JPML report, 144 individual lawsuits are pending in this MDL. Cases coordinated in an MDL keep their separate identity — they are managed together only for pretrial proceedings. Learn how MDLs work.
Related Antitrust MDLs
View categoryMultiPlan Health Insurance Provider Litigation
150
pending actions
MDL 3121
N.D. Illinois
Domestic Airline Travel Antitrust Litigation
105
pending actions
MDL 2656
D. District of Columbia
Payment Card Interchange Fee and Merchant Discount Antitrust Litigation
65
pending actions
MDL 1720
E.D. New York
Cathode Ray Tube (CRT) Antitrust Litigation
54
pending actions
MDL 1917
N.D. California